Automated Impella Controller (AIC), Product No. 0042-0000-US, 0042-0010-US, 0042-0040-US. Used with Impella Ventricular Support Systems (cardiovascular)
Published February 28, 2024 · Recall initiated: March 1, 2021
Summary
FDA records medical device Class II recall Z-1175-2024, published February 28, 2024 and initiated March 1, 2021. Recalling firm: Abiomed, Inc.; Status: Terminated; Reported quantity: 4,463 (US); Lot: Product Code 0042-0000-US UDI-DI 00813502010022; Product Code 0042-0010-US UDI-DI 00813502010985; Product Code 0042-0040-US UDI-DI 00813502011401; Software Versions V8.4 and V8.4.1. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Retrospective reporting for the release of Technical Bulletin IMP-2643 AIC Version 8.5 Software Update Available. The update resolved an issue in version 8.4 where a pump was not recognized by the AIC.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Abiomed, Inc.
- Distributor
- US Nationwide distribution.
- Lot
- Product Code 0042-0000-US UDI-DI 00813502010022; Product Code 0042-0010-US UDI-DI 00813502010985; Product Code 0042-0040-US UDI-DI 00813502011401; Software Versions V8.4 and V8.4.1
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAImpella Optical Controller, Packaged. Primary user control interface for the Impella Catheter, aNovember 4, 2026
- FDAImpella Connect Optical AIC, Packaged. Primary user control interface for the Impella Catheter, aNovember 4, 2026
- FDAAutomated Impella Controller, Packaged. Primary user control interface for the Impella Catheter,November 4, 2026
- FDAAutomated Impella Controller (AIC) with the below product descriptions and corresponding Product Codes. 1.September 30, 2026
- FDAAQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REFFebruary 28, 2024
- FDAAzurion 3 with a Certeray generator -To perform image guidance in diagnostic, interventional, and minimallyFebruary 28, 2024
Questions about this recall
Was Automated Impella Controller (AIC), Product No. 0042-0000-US, 0042-0010-US, 0042-0040-US. Used with Impella Ventricular Support Systems (cardiovascular) recalled?
Yes. FDA published recall Z-1175-2024 on February 28, 2024. Reported hazard: Retrospective reporting for the release of Technical Bulletin IMP-2643 AIC Version 8.5 Software Update Available. The update resolved an issue in version 8.4 where a pump was not recognized by the AIC.
What should I do if I have this product?
Voluntary: Firm initiated · Letter